MannKind share price logo

MannKind

NASDAQ: MNKD

Small Cap

$4.27

-0.12

(-2.84%)

as on

MannKind Stock Performance

as on August 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.13
    $4.36
    downward going graph

    3.28%

    Downside

    2.11%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.23
    $6.51
    downward going graph

    47.78%

    Downside

    52.46%

    Upside

    downward going graph

MannKind share price movements today

Previous Close
$4.39
Open
$4.36
Volume
3.3M
Market Cap
$1.2B
Day's Low - High
$4.13 - $4.36
52 Week Low - High
$2.23 - $6.51

MannKind Historical Returns

1 Month Return
-4.47 %
3 Month Return
+ 24.6 %
1 Year Return
+ 3.22 %
3 Year Return
-22.22 %
5 Year Return
-7.23 %

MannKind Stock Fundamentals & Key Indicators

Check MannKind market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.2B

EPS (TTM)

0.03

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.35%

PE Ratio (TTM)

0

PEG Ratio

4.3866

EBITDA

28.1M

Revenue (TTM)

393.6M

Profit Margin

-11.08%

Return On Equity TTM

0.00%

MannKind vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of MannKind with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
MannKind image
MannKind
BUY$1.2B-7.23%NA-11.08%NA
Revolution Medicines image
Revolution Medicines
BUY$43.7B669.3%NA0.00%NA
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$128.2B154.86%29.8286.04%NA
Regeneron image
Regeneron
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for MannKind Stock including INR - Dollar returns

The MannKind stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

MannKind investment value today

Current value as on today

₹1,25,892

Returns

₹25,892

(+25.89%)

Returns from MannKind Stock

₹14,477 (+14.48%)

Dollar Impact

₹11,415 (+11.42%)

Analyst Recommendation on MannKind Stock

Based on 6 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 6 analysts, 83.33333333333334% of analysts recommend a 'BUY' rating for MannKind. Average target price of $7.97

MannKind Share Price Target

Get share price movements and forecasts by analysts on MannKind.

What analysts predicted

46.42%UPSIDE

Target Price

$7.97

Current Price

$4.27

Analyzed by

6 Analysts

Target

$7.97

MannKind target price $7.97, a slight upside of 46.42% compared to current price of $4.27. According to 6 analysts rating.

Indian Investors' Interest in MannKind Stock

Search interest for MannKind Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:6% versus previous 30 day period

MannKind Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
66
72
70
76
78
76
82
111
90
109
Gross Profit
47
52
52
57
60
55
61
87
68
79
Operating Income
16
16
12
26
22
5
18
-7
-2
0
EBITDA
21
13
23
18
26
9
17
-2
2
12
Interest Expense
9
12
8
7
10
6
7
13
12
11
Depreciation
1
2
2
2
2
2
2
4
6
6
Income Before Tax
10
-1
12
8
13
0
7
-20
-16
-19
Income Tax Expense
0
0
1
1
0
0
0
-4
0
0
Net Income
10
-2
11
7
13
0
7
-15
-16
-19
Net Profit Margin
16.04%
-2.78%
16.48%
9.67%
16.79%
0.87%
9.72%
-14.25%
-18.43%
-17.40%

MannKind Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
174
11
27
63
65
75
99
198
285
348
Gross Profit
124
-5
7
35
40
36
42
136
208
287
Operating Income
67
-108
-76
-44
-47
-47
-64
8
72
38
EBITDA
64
-102
-75
-38
-44
-61
-56
15
77
27
Interest Expense
18
13
9
10
9
16
24
25
37
13
Depreciation
-
3
2
2
3
5
9
8
9
12
Income Before Tax
125
-117
-86
-51
-57
-80
-87
-10
30
1
Income Tax Expense
13
0
0
7
0
10
24
1
2
-4
Net Income
125
-117
-86
-51
-57
-80
-87
-11
27
5
Net Profit Margin
71.91%
-999.00%
-312.20%
-82.34%
-87.87%
-107.27%
-87.60%
-6.00%
9.66%
1.68%

MannKind Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
11
7
13
0
7
-15
-16
-19
Operating Cash Flow
3
9
22
-6
8
23
-7
-5
-18
Investing Cash Flow
-55
-41
48
5
6
-25
-291
18
17
Financing Cash Flow
-44
-2
-86
1
-5
71
247
-35
0
Change in Cash
-95
-34
-16
0
9
70
-52
-22
0

MannKind Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-117
-86
-51
-57
-80
-87
-11
27
5
Operating Cash Flow
-64
-37
-88
-28
-61
-80
34
42
18
Investing Cash Flow
16
0
-22
15
-151
4
-1
-96
-304
Financing Cash Flow
73
61
69
49
270
21
136
-137
315
Change in Cash
25
23
-41
36
57
-54
168
-191
28

Mutual Funds that own MannKind Stock

Check out the Mutual Funds with significant holdings in MannKind.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.911484%
12577014
Fidelity Salem Street Trust
1.025314%
3296804
Fidelity Concord Street Trust
0.960674%
3088959
TIAA-CREF Funds
0.811982%
2610853
Fidelity Select Portfolios
0.679572%
2185101
See all

Global Institutional Holdings in MannKind

Funds
Holdings
Vanguard
4.94%
iShares
4.6%
SPDR
3.14%
Janus Henderson
0.66%
First Trust
0.56%
See all

MannKind News & Key Events

    Insights on MannKind

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 2 quarters, 90.17M → 109.37M (in $), with an average increase of 17.6% per quarter

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 7 days, MNKD stock has moved up by 14.2%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Revolution Medicines, Inc. Common Stock has given 618.6% return, outperforming this stock by 626.3%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Revolution Medicines, Inc. Common Stock has given 488.4% return, outperforming this stock by 476.9%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 4 quarters, 7.98M → -19.03M (in $), with an average decrease of 106.2% per quarter

    About MannKind

    MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. It offers Afrezza inhalation powder, an inhaled insulin used to improve glycemic control in adults with diabetes; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults. Its products also include Tyvaso DPI for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; FUROSCIX, a furosemide injection to treat fluid buildup in patients with chronic heart failure or chronic kidney disease. The company's pipeline of treatments for orphan lung diseases include MNKD-201, a dry-powder formulation of nintedanib for the treatment of idiopathic pulmonary fibrosis and MNKD-701. It has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.
    OrganisationMannKind
    Headquarters1 Casper Street, Danbury, CT, United States, 06810
    IndustryBiotechnology
    CEODr. Michael E. Castagna Pharm.D.
    E-voting on sharesClick here to vote

    Key Management of MannKind

    Name

    Title

    Mr. Dominic Marasco R.Ph.

    President of Endocrine Business Unit

    Mr. Sanjay Singh M.B.A.

    Executive Vice President of Technical Operations

    Dr. Ajay Ahuja M.B.A., M.D.

    Executive VP & Chief Medical Officer

    Dr. Michael E. Castagna Pharm.D.

    CEO & Director

    Mr. Christopher B. Prentiss M.B.A.

    Chief Financial Officer

    Dr. David B. Thomson J.D., Ph.D.

    Executive VP, General Counsel & Secretary

    Dr. Stuart A. Tross Ph.D.

    Chief People & Workplace Officer

    FAQs

    What is MannKind share price today?

    MannKind share price today is $4.27 as on at the close of the market. MannKind share today touched a day high of $4.36 and a low of $4.13.

    What is the 52 week high and 52 week low for MannKind share?

    MannKind share touched a 52 week high of $6.51 on and a 52 week low of $2.23 on . MannKind stock price today i.e. is closed at $4.27,which is 34.41% down from its 52 week high and 91.48% up from its 52 week low.

    What is MannKind's market capitalisation today?

    MannKind market capitalisation is $0.00T as on .

    How to invest in MannKind Stock (MNKD) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for MannKind on INDmoney app. Click on Buy button. You can invest as low as $1.5 in MannKind Shares that will get you 0.3513 shares as per MannKind share price of $4.27 per share as on August 21, 2026 at 1:29 am IST.

    What is the minimum amount required to buy MannKind Stock (MNKD) from India?

    Indian investors can start investing in MannKind (MNKD) shares with as little as ₹95.695 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹956.95 in MannKind stock (as per the Rupee-Dollar exchange rate as on ). Based on MannKind share’s latest price of $4.27 as on August 21, 2026 at 1:29 am IST, you will get 2.3419 shares of MannKind. Learn more about fractional shares .

    What are the returns that MannKind has given to Indian investors in the last 5 years?

    MannKind stock has given -7.23% share price returns and 28.59% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?